←
Vikash R. Keshri, MD, PhD6,181 posts
Vikash R. Keshri, MD, PhD avatar

Vikash R. Keshri, MD, PhD

@docVRK

Doctor I Public Health I Health Policy & SystemsI Associate Professor @JindalGlobalUNI IAdj. Sr. Lecturer @UNSWMedicine I Think Global Act Local I Personal view

◷ Joined July 2010▧ 720 Photos and videos
Abantika Ghosh(অবন্তিকা) avatar
⟳ Vikash R. Keshri, MD, PhD retweeted
Abantika Ghosh(অবন্তিকা)@abantika77·Nov 13

As insurance cover increases, thru govt programmes where scrutiny of clinical decision making is negligible, instances like these will increase It is not imp whether spending is OOP or from exchequer. We need to look at health outcomes, not interventions #GamesHospitalsPlay

Who is to blame when financial incentives distort clinical decisions? Chhattisgarh’s C-section issues at CHC level expose failures in health financing and accountability. Public money must reward quality, not volume. @RemaNagarajan @AnantBhan Details: lnkd.in/p/dfDHuaRC

Post attachment
Hemant Deepak avatar
⟳ Vikash R. Keshri, MD, PhD retweeted
Hemant Deepak@HShewade·Nov 9

Thank you very much @ICMRDELHI for highlighting one of the many mentored OR/IR projects done under #NIEORCourses | #SORTIT | #MPHISOR Full text link of the mentored OR/IR publication being referred to that led to the state-level policy change: pubmed.ncbi.nlm.nih.gov/4263…

Post attachment

🇮🇳 #WeAreICMR: Research that made an Impact! 🔬 @icmr_nie TB SORT IT course trains & mentors state-level researchers to generate actionable evidence, strengthening advocacy for nutritional support for undernourished #TB patients in #Chhattisgarh. #Tuberculosis #PublicHealth

Post attachmentPost attachment
Vikash R. Keshri, MD, PhD avatar
Vikash R. Keshri, MD, PhD@docVRK·Nov 2

Medicines are a necessity, not a luxury. India needs stronger NPPA oversight and effective price regulation to ensure life-saving drugs remain affordable and accessible to all. Healthcare affordability is a public health imperative. 👇 indianexpress.com/article/ex…

Rema Nagarajan avatar
⟳ Vikash R. Keshri, MD, PhD retweeted
Rema Nagarajan@RemaNagarajan·Oct 28

MRP of some of the most expensive cancer drugs remain unchanged Most are by multinational pharma companies, many are patented Almost all are unaffordable for 95% of Indians So they don't give high margins to hospitals? Really?? What abt their buy one get one free kind of schemes?

Post attachment
Vikash R. Keshri, MD, PhD avatar
Vikash R. Keshri, MD, PhD@docVRK·Aug 6

ON #NEET “What is the alternative? How do you holistically assess two million students?” Breaking free from the MCQ trap and introducing interview-based or subjective alternatives risks “elite capture.” I argue in @ThePrintIndia theprint.in/past-forward/ind…

Rema Nagarajan avatar
⟳ Vikash R. Keshri, MD, PhD retweeted
Rema Nagarajan@RemaNagarajan·Jul 18

Dropping last pretence that medical education should be non-profit Now NMC drafts regulation amendment to allow for-profit companies to start med colleges Now India can accept openly that education, like healthcare, is an industry free to make max profits timesofindia.indiatimes.com/…